Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial.
BMC Pulm Med. 2020 Jun 5;20(1):160. doi: 10.1186/s12890-020-01198-4.
BMC Pulm Med. 2020.
PMID: 32503515
Free PMC article.
Clinical Trial.